Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alkem Laboratories Ltd.
NSE: ALKEM
|
BSE: 539523
|
ISIN: INE540L01014
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
5668.5000
25.00
(
0.44
%)
NSE
Nov 07, 2025
15:44 PM
Near 52W High of ₹5958.90
Volume:
226.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alkem Laboratories Ltd.
08 Nov 2023
5668.50
0.44%
Alkem Labs (HOLD): Sizeable margin gains; tax guided to reduce raise to HOLD
Hold:
Alkem Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3850
Recommendation
Target
BOB Capital Markets Ltd.
Q2 EBITDA/PAT outstripped consensus by 44%/54% on higher margins, strong US growth and low taxes
Alkem Laboratories Ltd. is trading above all available SMAs
More from Alkem Laboratories Ltd.
Recommended
Market trades flat, Pricol's Q2FY26 net profit grows 42% YoY
Trendlyne Marketwatch |
07 Nov 2025, 03:26PM
The banking boom: Rising profits, and a wave of investor confidence
The Baseline |
06 Nov 2025, 03:07PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
|
02 Jul 2021